Health in Argentina 1,098 indicators covering health for Argentina. IndicatorLatest Year10-yr change Rank Affordability - percentage of GDP per capita required to purchase 1.7 2022 up 33.9% 143rd Health expenditure and financing per capita 2,851 2023 up 0.3% 36th Road deaths over the long term 5,420 2017 down 5.9% 8th Malaria cases reported 0 2024 — 81st Deaths and missing persons due to natural disasters 0.03 2023 down 82.4% 106th Mean systolic blood pressure 119 2009 down 1.4% 169th Mean fasting blood glucose (mmol/l) 5.5 2009 up 1.9% 47th Hiv expenditure 0 2022 down 100.0% 101st Number of new leprosy cases with G2D among children 0 2024 — 35th Most sold brand of cigarettes - price in currency reported 141 2020 up 2,520.8% 67th Most sold brand of cigarettes - taxes as a % of price - total tax 0.8% 2020 up 11.6% 31st Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.6% 2020 up 19.6% 8th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 33rd Most sold brand of cigarettes - taxes as a % of price - other taxes 0.2% 2020 down 5.6% 3rd Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 unchanged 149th Most sold brand of cigarettes - taxes as a % of price - specific 0.0% 2020 — 128th Most sold brand of cigarettes - price in US$ at official exchange 1.95 2020 up 42.3% 117th Import of environmentally sound technologies 3.75 billion 2020 down 17.5% 47th Percentage of people living with HIV who know their HIV status 96 2025 up 5.5% 9th Percentage of people living with HIV who know their status receiving 78 2025 up 23.8% 94th Most sold brand of cigarettes - price in PPP$ 4.83 2020 up 102.9% 110th Export of environmentally sound technologies 472.56 million 2020 down 80.9% 66th Pcv3 number unvaccinated 147,302 2023 up 42.6% 27th Avoidable mortality 99,807 Deaths 2023 up 2.4% 11th Avoidable mortality — Preventable mortality 47,416 Deaths 2023 down 6.2% 15th Avoidable mortality — Treatable mortality 52,391 Deaths 2023 up 11.6% 8th Reported number of human rabies deaths 0 2024 — 62nd Proportion of births delivered in a health facility (Facility births) 97.8% 2021 down 1.7% 55th Number of non-autochthonous leprosy cases 16 2024 down 78.9% 11th Number reported cases of cholera 12 1998 down 99.5% 50th Maternal mortality ratio 34.3 2022 down 1.7% 32nd HPV immunization coverage estimates among primary target cohort (9-14) 61.0% 2025 down 28.2% 78th Life expectancy at birth oecd 75.4 2022 down 0.9% 36th How many health warnings are approved by the law for cigarette 10 2022 unchanged 66th Tuberculosis - new and relapse cases 9,610 2011 down 16.1% 60th Number of reported cholera deaths 0 1998 down 100.0% 37th Physiotherapists 35,556 2023 up 40.4% 9th Diarrhea treatment 15.4% 2020 down 12.0% 94th Pregnant women receiving prenatal care 95.0% 2020 down 3.2% 54th Coverage of the human papillomavirus vaccine 67 2024 up 55.8% 35th Generalist medical practitioners 4,495 2023 up 16.8% 52nd Percentage of principal display area mandated to be covered by health 50 2022 unchanged 80th Average of 13 International Health Regulations core capacity scores 70.22 2017 up 4.8% 96th New cases: pulmonary smear-negative 1,327 2012 down 18.1% 72nd Percentage of principal display area mandated to be covered by health 50 2022 unchanged 73rd Percentage of principal display area mandated to be covered by health 50 2022 unchanged 80th Average death rate due to natural disasters 0 2019 down 100.0% 111th Number of full-time equivalent staff in national agency 4 2022 unchanged 59th Total number of notified TB cases 10,038 2014 down 16.9% 57th The number of people with susceptibility test result for rifampicin 2,309 2021 — 44th Specialist medical practitioners 51,727 2023 down 6.7% 20th New cases: pulmonary smear unknown/not done 1,014 2012 down 57.2% 26th Smear-positive tuberculosis treatment-success rate 52.0% 2011 down 14.8% 175th Share of one year olds who received the rotavirus vaccine 73 2024 up 19.7% 75th How many health warnings are approved by the law for other smoked 10 2022 unchanged 62nd Insufficiently active 84.8 2016 down 0.4% 48th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 67th The number of people with susceptibility test result for rifampicin 36.41 2021 — 127th Contraceptive prevalence, any method 59.1% 2020 up 6.5% 9th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 67th ← Previous Page 17 of 19 Next →